🟢 Pacific Biosciences is trading 10% up today amid broader-market gains

Pacific Biosciences is trading at $2.79, up +10.04%, amid broader-market support; no clear new company-specific trigger was identified.

• Its press-release archive listed no October 5 announcement; the latest listed release was September 3.
• The earlier EpiSign METRIC 5-base launch was linked to the prior surge, not identified as a fresh October 5 catalyst.
• Broader markets were higher, with the Nasdaq Composite up +0.96%.